研究报告 |
|
|
|
|
抗IgE单链抗体在大肠杆菌中可溶性高效表达条件的研究 |
刘启刚1,2, 代云见2, 张勇侠2, 王保成2, 王明蓉2 |
1. 中国医药集团总公司四川抗菌素工业研究所 成都 610052; 2. 成都生物制品研究所有限责任公司 成都 610023 |
|
Efficient Soluble Expression of Anti-IgE scFv in E.coli and Optimization of Expression Conditions |
LIU Qi-gang1,2, DAI Yun-jian2, ZHANG Yong-xia2, WANG Bao-cheng2, WANG Ming-rong2 |
1. Sichuan Industrial Institute of Antibiotics, Chengdu 610052, China; 2. Chengdu Institute of Biological Products Co., Ltd., Chengdu 610023, China |
引用本文:
刘启刚, 代云见, 张勇侠, 王保成, 王明蓉. 抗IgE单链抗体在大肠杆菌中可溶性高效表达条件的研究[J]. 中国生物工程杂志, 2012, 32(11): 23-28.
LIU Qi-gang, DAI Yun-jian, ZHANG Yong-xia, WANG Bao-cheng, WANG Ming-rong. Efficient Soluble Expression of Anti-IgE scFv in E.coli and Optimization of Expression Conditions. China Biotechnology, 2012, 32(11): 23-28.
链接本文:
https://manu60.magtech.com.cn/biotech/CN/
或
https://manu60.magtech.com.cn/biotech/CN/Y2012/V32/I11/23
|
[1] Gould H J, Sutton B J. IgE in allergy and asthma today. Nature Reviews Immunology, 2008, 8: 205-217. [2] Maloney J M, Rudengren M, Ahlstedt S, et al. The use of serum-specific IgE measurements for the diagnosis of peanut, tree nut, and seed allergy. The Journal of Allergy and Clinical Immunology, 2008, 122(1): 145-151. [3] 李明华,殷凯生,朱桂立.哮喘病学.北京:人民卫生出版社,2005.65-75. Li M H, Yin K S, Zhu G L. Asthmology. Beijing:People's Medical Publishing House, 2005.65-75. [4] Laffer S, Lupinek C, Rauter I, et al. A high-affinity monoclonal anti-IgE antibody for depletion of IgE and IgE-bearing cells. Allergy, 2008, 63(6):695-702. [5] Wang M, Zhang Y, Du T, et al. Bacterial expression and characterization of a novel human anti-IgE scFv fragment. MAbs, 2011, 3(5):495-499. [6] Takayuki O, Miyo A O, et al. Suppression of IgE B Cells and IgE Binding to FcεRI by Gene Therapy with Single-Chain Anti-IgE. The Journal of Immunology, 2009,182(12):8110-8117. [7] Boushey H A. Experiences with monoclonal antibody therapy for allergic asthma. Allergy Clin Immunol, 2001, 108(Supp 12):S77-S83. [8] Xiang D, Zhang J, Chen Y, et al. Expressions and purification of a mature form of recombinant human Chemerin in Escherichia coli. Protein Expr Purif, 2010, 69(2):153-158. [9] Terpe K. Overview of bacterial expression systems for heterologous protein production: from molecular and biochemical fundamentals to commercial systems. Appl Microbiol Biot ech nol, 2006, 72(2):211-222. [10] Wang Z S, Xiang Q J, Wang H Y, et al. Cloning and optimizing expression of a periplasmic solute-binding gene gsiB from Escherichia coli. Journal of Genetics and Genomics, 2010, 32(5):505-511. [11] Schirrmann T, Al-Halabi L, Dübel S, et al. Production systems for recombinant antibodies. Fronti Biosci, 2008,5(1):4576-4594. [12] Jordan E, Hust M, Roth A, et al. Production of recombinant antibody fragments in bacillus megaterium. Microbial Cell Fact, 2007, 6: 2. [13] Paola J, Lorenzo V, Luis A, et al. Thioredoxin fusions Increase folding of single chain Fv antibodies in the cytoplasm of Escherichia coli: evidence that chaperone activity is the prime effect of Thioredoxin. J Mol Biol, 2006, 357(1): 49-61. [14] Olaofea O A, Burtona S G, Cowan D A, et al. Improving the production of a thermostable amidase through optimising IPTG induction in a highly dense culture of recombinant Escherichia coli. Biochemical Engineering Journal, 2010, 52(1): 19-24. |
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|